Nahoko Shoji

Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan

Yoshinobu Kanda, Shin Mineishi, Takeshi Saito et al. · Bone Marrow Transplantation · 2001 · 107 citations

Cell Therapy, Transplantation, Cmv Antigenemia Assay +12

Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma.

Takeshi Saito, Yoshinobu Kanda, Masahiro Kami et al. · PubMed · 2002 · 56 citations

Clinico-hematologic Features of Myelodysplastic Syndrome Presenting as Isolated Thrombocytopenia: An Entity with a Relatively Favorable Prognosis

Goro Sashida, Tomoiku Takaku, Nahoko Shoji et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2003 · 36 citations

Thrombopoiesis, Thrombosis, Hematological Malignancy +15

Use of real-time PCR to monitor human herpesvirus 6 reactivation after allogeneic bone marrow transplantation.

Junko H. Ohyashiki, Akitaka Suzuki, K Aritaki et al. · International Journal of Molecular Medicine · 2000 · 26 citations

Diagnostic Virology, Transplantation, Marrow Transplantation +15

Re-evaluation of refractory anemia with excess blasts in transformation

Kazuma Ohyashiki, J Nishimaki, Nahoko Shoji et al. · Leukemia Research · 2001 · 19 citations

Laboratory Hematology, Hematology, Refractory Anemia +3